Adverse Outcomes and Mortality in Liver Transplant
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorMayo Clinic
About this trial
Prospective natural history pilot study to explore the link between muscle composition using an MRI-based Muscle Assessment Score (MAsS) and adverse outcomes in liver transplant candidates.
Eligibility criteria
Qualifiers
All patients with end-stage liver disease undergoing evaluation for liver transplantation
Patient clinically indicated for MRI during transplant candidacy evaluation
Adult
Disqualifiers
None
Trial design
Treatments tested in this trial
- MAsS
Treatment groups
100 Participants
are divided into 1 treatment groupSponsors and collaborators
Mayo Clinic
Lead sponsor
Amra Medical AB
Collaborator
Source ClinicalTrials.gov